Loading...

GFR WITH CYSTATIN C (ABOVE 18 YEARS), SERUM

image not found

NABL Cap Accredited 
GFR with Cystatin C (Above 18 Years), Serum is a specialized kidney-function test that estimates Glomerular Filtration Rate using Cystatin C—a highly reliable marker unaffected by muscle mass. This test provides a more accurate assessment of early kidney damage compared to creatinine-based methods. Performed with advanced biochemical analysis by Metropolis Healthcare, it is ideal for adults requiring precise monitoring of kidney health.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,457.00

Sample Type: SERUM

Fasting Not Required


Frequently Asked Questions (FAQ's):

What does the GFR with Cystatin C test measure at Metropolis Healthcare?
It measures serum Cystatin C to calculate a more accurate GFR, helping Metropolis Healthcare assess kidney filtration efficiency.

How does Metropolis Healthcare perform the Cystatin C test?
Metropolis Healthcare uses advanced immunoassay technology for precise Cystatin C measurement and accurate GFR estimation.

Who should take this kidney-function test?
Adults with diabetes, hypertension, chronic kidney disease, or those at risk of renal impairment can benefit from this Metropolis Healthcare test.

Is fasting required for the GFR with Cystatin C test at Metropolis Healthcare?
Fasting is not required; Metropolis Healthcare only needs a blood sample for analysis.

Why is Cystatin C preferred over creatinine in some cases?
Cystatin C is not affected by muscle mass, diet, or age, allowing Metropolis Healthcare to detect early kidney dysfunction more reliably.

Can this test detect early kidney disease?
Yes, it is highly sensitive for early renal impairment and is used by Metropolis Healthcare for more accurate risk assessment.

How soon will I receive my GFR with Cystatin C report?
Results are provided within the standard Metropolis Healthcare turnaround time.

Can this test help monitor existing kidney conditions?
Yes, Metropolis Healthcare often recommends it for ongoing monitoring of chronic kidney disease progression.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab